VASCONCELLES MICHAEL
Head of Research and Dev.
VASCONCELLES MICHAEL has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 23, 2026.
On the most recent filing, VASCONCELLES MICHAEL is listed as Head of Research and Dev. at Day One Biopharmaceuticals, Inc. Inside the rolling window, VASCONCELLES MICHAEL reported no open-market purchases and 1 open-market sale totaling $32K in DAWN.
Companies traded
Other insiders at DAWN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$32K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has VASCONCELLES MICHAEL made?
VASCONCELLES MICHAEL has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does VASCONCELLES MICHAEL trade?
VASCONCELLES MICHAEL has filed SEC Form 4 disclosures for 1 company, including DAWN.
When was VASCONCELLES MICHAEL's most recent SEC Form 4 filing?
VASCONCELLES MICHAEL's most recent SEC Form 4 filing on Tracefour is dated Apr 23, 2026.
What is VASCONCELLES MICHAEL's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, VASCONCELLES MICHAEL is listed as Head of Research and Dev..
What is VASCONCELLES MICHAEL's total buy and sell value in the current window?
Inside the rolling retention window, VASCONCELLES MICHAEL bought $0 and sold $32K based on SEC Form 4 filings.
What was VASCONCELLES MICHAEL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,728 DAWN shares on 2026-02-17, worth $32K, per SEC Form 4 filings.